Cubist Systematic Strategies, LLC Roivant Sciences Ltd. Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$9.87 - $11.8 $117,354 - $140,302	11,890 New	11,890 $125,000
Q3 2023 Nov 14, 2023	SELL	$9.76 - $13.19 $907,328 - $1.23 Million	-92,964 Reduced 94.82%	5,078 $59,000
Q2 2023 Aug 14, 2023	BUY	$7.09 - $10.08 $565,590 - $804,111	79,773 Added 436.66%	98,042 $988,000
Q1 2023 May 15, 2023	BUY	$6.92 - $9.98 $50,896 - $73,402	7,355 Added 67.39%	18,269 $134,000
Q4 2022 Feb 14, 2023	BUY	$3.36 - $7.99 $36,671 - $87,202	10,914 New	10,914 $87,000
Q2 2022 Aug 15, 2022	BUY	$2.81 - $4.84 $2,804 - $4,830	998 New	998 $4,000

314

495M

1.29M

1.15M

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.28B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.